VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 196 filers reported holding VIKING THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5,655,322 | +21.6% | 339,659 | -31.4% | 1.11% | +15.4% |
Q4 2022 | $4,652,436 | +204.1% | 494,940 | +147.4% | 0.96% | +132.0% |
Q4 2018 | $1,530,000 | -68.5% | 200,047 | -28.2% | 0.42% | -42.5% |
Q3 2018 | $4,855,000 | +38.6% | 278,712 | -24.5% | 0.72% | +30.8% |
Q2 2018 | $3,503,000 | +154.4% | 369,082 | +17.2% | 0.55% | +141.0% |
Q1 2018 | $1,377,000 | -10.4% | 315,001 | -16.8% | 0.23% | -16.7% |
Q4 2017 | $1,537,000 | – | 378,520 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |